Screening for Hemochromatosis: High Prevalence and Low Morbidity in an Unselected Population of 65,238 Persons

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Scandinavian Journal of Gastroenterology

• Publication date

  2001-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/003655201750422747PMID 11589387
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence of hemochromatosis in Finland.

  2009cited by this paper
• The Statistical Analysis of Failure Time Data

  2003cited by this paper
• Screening for hemochromatosis.

  2002cited by this paper
• HUMAN SERUM TRANSFERRIN

  2000cited by this paper
• Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis

  2000cited by this paper
• Population screening for hemochromatosis: A comparison of unbound iron‐binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors

  2000cited by this paper
• EASL International Consensus Conference on Haemochromatosis.

  2000cited by this paper
• The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects.

  2000cited by this paper
• HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis

  2000influential reference
• Haemochromatosis in the new millennium.

  2000cited by this paper
• Molecular medicine and hemochromatosis: at the crossroads.

  1999cited by this paper
• A population-based study of the clinical expression of the hemochromatosis gene.

  1999cited by this paper
• High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression.

  1999influential reference
• Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis

  1999cited by this paper
• Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri.

  1999cited by this paper
• Screening for Hemochromatosis and Iron Deficiency in Employees and Primary Care Patients in Western Germany

  1998cited by this paper
• Neuromuscular Disorders: Clinical and Molecular Genetics

  1998cited by this paper
• Iron Overload, Public Health, and Genetics: Evaluating the Evidence for Hemochromatosis Screening

  1998cited by this paper
• HFE mutations in patients with hereditary haemochromatosis in Sweden

  1998cited by this paper
• Hereditary hemochromatosis: gene discovery and its implications for population-based screening.

  1998cited by this paper
• Prevalence of Hereditary Hemochromatosis in 16 031 Primary Care Patients

  1998cited by this paper
• The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis

  1997cited by this paper
• Prevalence of hemochromatosis among first-time and repeat blood donors in Norway.

  1997cited by this paper
• Global prevalence of putative haemochromatosis mutations.

  1997cited by this paper
• A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis

  1996cited by this paper
• Long-term survival in patients with hereditary hemochromatosis.

  1996cited by this paper
• Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis.

  1996influential reference
• Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older.

  1995cited by this paper
• Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database.

  1995cited by this paper
• Clinical spectrum and management of haemochromatosis.

  1994cited by this paper
• Epidemiology, clinical spectrum and prognosis of hemochromatosis.

  1994cited by this paper
• Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis.

  1994cited by this paper
• 7 Clinical spectrum and management of haemochromatosis

  1994cited by this paper
• Cost-effectiveness of screening for hereditary hemochromatosis.

  1994cited by this paper
• Preventing Manifestations of Hereditary Haemochromatosis through Population Based Screening

  1994cited by this paper
• Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients.

  1994cited by this paper
• Screening for hemochromatosis.

  1993cited by this paper
• Screening for haemochromatosis: prevalence among Danish blood donors

  1991cited by this paper
• Prevalence of hereditary haemochromatosis in two Swedish urban areas

  1989cited by this paper
• Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis

  1986cited by this paper
• Pathology of the Liver

  1981cited by this paper
• The Statistical Analysis of Failure Time Data

  1980cited by this paper
• Iron-storage disease.

  1956cited by this paper
• Iron storage disease.

  1955cited by this paper
• An Introduction to Medical Statistics

  1932cited by this paper

• Patient Insights into and Satisfaction with Treatment, Management, and Clinical Research of Hereditary Hemochromatosis

  2025cites this paper
• Diagnosis and Treatment of Hemochromatosis.

  2025cites this paper
• Influence of Genetic Polymorphisms and Biochemical Biomarkers on Response to Nutritional Iron Supplementation and Performance in a Professional Football Team: A Pilot Longitudinal Study

  2025cites this paper
• Diagnosis and Treatment of HFEC282Y-Linked Hemochromatosis.

  2025cites this paper
• Preparatory work for the update of the tolerable upper intake levels for iron

  2024cites this paper
• Non-expressing homozygous C282Y carriers and haemochromatosis

  2024cites this paper
• Mortality and risk of diabetes, liver disease, and heart disease in individuals with haemochromatosis HFE C282Y homozygosity and normal concentrations of iron, transferrin saturation, or ferritin: prospective cohort study

  2024influential citation
• Hemochromatosis—How Not to Overlook and Properly Manage “Iron People”—A Review

  2024cites this paper
• Health Economic Evaluations of Hemochromatosis Screening and Treatment: A Systematic Review

  2024influential citation
• The Evolution of Iron-Related Comorbidities and Hospitalization in Patients with Hemochromatosis: An Analysis of the Nationwide Inpatient Sample

  2023cites this paper
• HEREDITARY HEMOCHROMATOSIS: THE ROLE OF PROTEINS IN IRON HOMEOSTASIS

  2023cites this paper
• Paroxysmal atrial fibrillation and hemochromatosis: a narrative review

  2023cites this paper
• Arthritis Prediction of Advanced Hepatic Fibrosis in HFE Hemochromatosis.

  2022cites this paper
• Twenty-Five Years of Contemplating Genotype-Based Hereditary Hemochromatosis Population Screening

  2022cites this paper
• Bloodlettings in Hemochromatosis Result in Increased Blood Lead (Pb) Concentrations

  2022cites this paper
• Iron effects versus metabolic alterations in hereditary hemochromatosis driven bone loss.

  2022cites this paper
• Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers

  2021cites this paper
• Abdominal pain and cirrhosis at diagnosis of hemochromatosis: Analysis of 219 referred probands with HFE p.C282Y homozygosity and a literature review

  2021cites this paper
• HFE Genotype, Ferritin Levels and Transferrin Saturation in Patients with Suspected Hereditary Hemochromatosis

  2021cites this paper
• Genetic diagnosis history and osteoarticular phenotype of a non-transfusion secondary hemochromatosis

  2020cites this paper
• Evaluation of a screening program for iron overload andHFE mutations in 50,493 blood donors

  2020cites this paper
• Cold agglutinin disease revisited: A multinational, observational study of 232 patients.

  2020cites this paper
• Chelating Polymers for Hereditary Hemochromatosis Treatment.

  2020cites this paper
• Association between hereditary hemochromatosis and hepatocellular carcinoma: a comprehensive review

  2020cites this paper
• Iron overload associated symptoms and laboratory changes in the Swiss Haemochromatosis Cohort - when a clinician should become attentive.

  2020cites this paper
• Cytokine and Gene Expression Profiling in Patients with HFE-Associated Hereditary Hemochromatosis according to Genetic Profile

  2020cites this paper
• Contemporary Epidemiology of Cirrhosis

  2019cites this paper
• Hemochromatosis

  2019cites this paper
• Iron-Induced Liver Injury: A Critical Reappraisal

  2019cites this paper
• Modern Outcomes Following Treatment of Hepatocellular Carcinoma in Hereditary Hemochromatosis

  2019influential citation
• Dehydrated hereditary stomatocytosis: clinical perspectives

  2019cites this paper
• Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank

  2019cites this paper
• Higher age at diagnosis of hemochromatosis is the strongest predictor of the occurrence of hepatocellular carcinoma in the Swiss hemochromatosis cohort

  2018cites this paper
• Genomic and Strontium Isotope Variation Reveal Immigration Patterns in a Viking Age Town.

  2018cites this paper
• Diagnosis and therapy of genetic haemochromatosis (review and 2017 update)

  2018cites this paper
• Hemochromatosis - modern condition of the problem.

  2018cites this paper
• How to use… iron studies

  2018cites this paper
• The Epidemiology of Rare Hereditary Metabolic Liver Diseases

  2018cites this paper
• Unbound Iron Binding Capacity (UIBC) – An Alternative Lab Parameter for Iron Stores?

  2018cites this paper
• Chapter 118 – Hemochromatosis

  2017cites this paper
• Cost-Effectiveness of Different Population Screening Strategies for Hereditary Haemochromatosis in Australia

  2017cites this paper
• Diabetes in HFE Hemochromatosis

  2017cites this paper
• Interpreting iron studies

  2017cites this paper
• Iron loading in HFE p.C282Y homozygotes found by population screening: relationships to HLA-type and T-lymphocyte subsets

  2017cites this paper
• S 8 Functional variation in ancient samples

  2017cites this paper
• Clinical burden of liver disease from hemochromatosis at an academic medical center

  2017cites this paper
• Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes

  2017cites this paper
• Interpreting Iron Studies

  2017cites this paper
• Iron mediated toxicity and programmed cell death: A review and a re-examination of existing paradigms.

  2017cites this paper
• Haemochromatosis.

  2016cites this paper
• Erythrocytapheresis, a treatment modality in hereditary hemochromatosis

  2016cites this paper
• The Health Economics of Haemochromatosis

  2016cites this paper
• Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model

  2016cites this paper
• GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes.

  2016cites this paper
• Quality of life utility values for hereditary haemochromatosis in Australia

  2016cites this paper
• ALTERACIONES DEL METABOLISMO DEL HIERRO

  2015cites this paper
• A Systematic Review and Narrative Synthesis of Health Economic Studies Conducted for Hereditary Haemochromatosis

  2015influential citation
• Examining the clinical use of hemochromatosis genetic testing.

  2015cites this paper
• Homozygosity For The C282Y Substitution In The HFE Gene: The Incomplete Penetrance And Variable Expressivity

  2015cites this paper
• The effect of iron oxide nanoparticles on T lymphocytes

  2015cites this paper
• Lymphocytes in hemochromatosis: a genomic and functional approach

  2015influential citation
• Update on iron metabolism and molecular perspective of common genetic and acquired disorder, hemochromatosis.

  2015cites this paper
• Clinical Manifestation of Hereditary Hemochromatosis and Prevalence of Hepatocellular Carcinoma in the Swiss Hemochromatosis Cohort

  2015influential citation
• Bloodletting therapy in hemochromatosis: Does it affect trace element homeostasis?

  2015cites this paper
• Scandinavian epidemiological research in gastroenterology and hepatology

  2015cites this paper
• Relationship of Baseline Hemoglobin Level with Serum Ferritin, Postphlebotomy Hemoglobin Changes, and Phlebotomy Requirements among HFE C282Y Homozygotes

  2015cites this paper
• Effects of strain and age on hepatic gene expression profiles in murine models of HFE-associated hereditary hemochromatosis

  2014influential citation
• Erythrocytapheresis compared with whole blood phlebotomy for the treatment of hereditary haemochromatosis.

  2014cites this paper
• Improved detection of hereditary haemochromatosis

  2014cites this paper
• Analysis of HFE Genes C282Y, H63D, and S65D in Patients With Hyperferritinemia From Northeastern Brazil

  2014cites this paper
• Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis.

  2013cites this paper
• Does hemochromatosis predispose to celiac disease? A study of 29,096 celiac disease patients

  2013cites this paper
• A Computational Model of Liver Iron Metabolism

  2013cites this paper
• What is the future of research for hereditary hemochromatosis in Turkey.

  2013cites this paper
• Genotype-Phenotype Relationship in Hereditary Haemochromatosis

  2013cites this paper
• Contribution à la description phénotypique et à l'étude des patients atteints d'hémochromatose HFE

  2013influential citation
• Türk Tip 2 Diabetik Hastalar Arasında HFE Gen Mutasyonu

  2013cites this paper
• Cancer risk in HFE C282Y homozygotes: results from the HUNT 2 study

  2013cites this paper
• Erosive and inflammatory joint changes in hereditary hemochromatosis arthropathy detected by low-field magnetic resonance imaging

  2013cites this paper
• HFE Gene Mutation Among Turkish Patients with Type 2 Diabetes Mellitus

  2013cites this paper
• Effects of Highly Conserved Major Histocompatibility Complex (MHC) Extended Haplotypes on Iron and Low CD8+ T Lymphocyte Phenotypes in HFE C282Y Homozygous Hemochromatosis Patients from Three Geographically Distant Areas

  2013cites this paper
• Hemochromatosis and iron overload: from bench to clinic.

  2013cites this paper
• Iron Metabolism and Related Disorders

  2013cites this paper
• Just Genetics: How far does the moratorium on the use of genetic data by insurers within the UK accord with Rawls’ principles of justice?

  2013cites this paper
• effective approach Screening for hemochromatosis by measuring ferritin levels: a more

  2013cites this paper
• Hemochromatosis: the new blood donor.

  2013cites this paper
• Iron Biomarkers in Plasma, HFE Genotypes, and the Risk for Colorectal Cancer in a Prospective Setting

  2012cites this paper
• Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable to the general population

  2012cites this paper
• Iron mobilization using chelation and phlebotomy.

  2012cites this paper
• Blood pressure, obesity, serum iron and lipids as risk factors of ischaemic heart disease.: The HUNT study, Norway.

  2012cites this paper
• Screening for hereditary haemochromatosis.

  2012cites this paper
• Irish Hospital Consultant Views On The Management Of Hereditary Haemochromatosis And Analysis Of The Differences Between 'Common Practice' And The Management Guidelines Available.

  2012cites this paper
• Iron chelation therapy in myelodysplastic syndrome.

  2012cites this paper
• Natural History and Management of HFE-Hemochromatosis

  2011cites this paper
• Hepatic Iron Overload

  2011cites this paper
• Hemochromatosis and Iron Storage Disorders

  2011cites this paper
• Diagnosis and management of hereditary haemochromatosis

  2011cites this paper
• Low prevalence of hereditary hemochromatosis in multiethnic populations in Northern Norway

  2011cites this paper
• 26. Iron Overload States

  2011cites this paper
• For the full versions of these articles see bmj

  2011cites this paper